Significant Price Reduction for DR-TB Drug Marks Progress in Global Health Access TB Alliance's innovative approach has led to a remarkable 25% price cut for pretomanid, a critical medication for drug-resistant tuberculosis, expanding global access.

Significant Price Reduction for DR-TB Drug Marks Progress in Global Health Access #United_States #New_York #TB_Alliance #pretomanid #drug-resistant_TB